vs
Side-by-side financial comparison of FONAR CORP (FONR) and PARK AEROSPACE CORP (PKE). Click either name above to swap in a different company.
FONAR CORP is the larger business by last-quarter revenue ($25.5M vs $17.3M, roughly 1.5× PARK AEROSPACE CORP). PARK AEROSPACE CORP runs the higher net margin — 17.0% vs 8.0%, a 9.0% gap on every dollar of revenue. On growth, PARK AEROSPACE CORP posted the faster year-over-year revenue change (20.3% vs 2.4%). PARK AEROSPACE CORP produced more free cash flow last quarter ($4.3M vs $-227.0K). Over the past eight quarters, PARK AEROSPACE CORP's revenue compounded faster (3.0% CAGR vs -0.3%).
FONAR Corp is a specialized medical technology firm that designs, manufactures, and distributes innovative MRI systems including upright and open models. It primarily serves U.S. hospitals, diagnostic imaging centers, and healthcare providers, delivering high-precision scanning solutions for clinical diagnostic use.
Park Electrochemical Corp, now called the Park Aerospace Corp, is a Melville, New York-based materials manufacturer for the telecommunications, Internet infrastructure, high-end computing, and aerospace industries. It produces high-technology digital and radio frequency(RF)/microwave printed circuit material products, composite materials. Its printed circuit materials are used for complex multilayer printed circuit boards and other electronic interconnection systems, such as multilayer back-p...
FONR vs PKE — Head-to-Head
Income Statement — Q2 FY2026 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $25.5M | $17.3M |
| Net Profit | $2.1M | $3.0M |
| Gross Margin | — | 34.1% |
| Operating Margin | 13.5% | 21.0% |
| Net Margin | 8.0% | 17.0% |
| Revenue YoY | 2.4% | 20.3% |
| Net Profit YoY | 4.7% | 87.1% |
| EPS (diluted) | — | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $25.5M | $17.3M | ||
| Q3 25 | $26.0M | $16.4M | ||
| Q2 25 | $27.3M | $15.4M | ||
| Q1 25 | $27.2M | $16.9M | ||
| Q4 24 | $24.9M | $14.4M | ||
| Q3 24 | $25.0M | $16.7M | ||
| Q2 24 | $25.9M | $14.0M | ||
| Q1 24 | $25.7M | $16.3M |
| Q4 25 | $2.1M | $3.0M | ||
| Q3 25 | $2.3M | $2.4M | ||
| Q2 25 | $729.3K | $2.1M | ||
| Q1 25 | $2.5M | $1.2M | ||
| Q4 24 | $2.0M | $1.6M | ||
| Q3 24 | $3.1M | $2.1M | ||
| Q2 24 | $830.4K | $993.0K | ||
| Q1 24 | $1.9M | $2.7M |
| Q4 25 | — | 34.1% | ||
| Q3 25 | — | 31.2% | ||
| Q2 25 | — | 30.6% | ||
| Q1 25 | — | 29.3% | ||
| Q4 24 | — | 26.6% | ||
| Q3 24 | — | 28.5% | ||
| Q2 24 | — | 29.3% | ||
| Q1 24 | — | 27.3% |
| Q4 25 | 13.5% | 21.0% | ||
| Q3 25 | 14.1% | 17.4% | ||
| Q2 25 | 5.3% | 15.7% | ||
| Q1 25 | 15.2% | 16.8% | ||
| Q4 24 | 11.9% | 12.8% | ||
| Q3 24 | 21.0% | 15.7% | ||
| Q2 24 | 7.4% | 14.9% | ||
| Q1 24 | 16.8% | 15.7% |
| Q4 25 | 8.0% | 17.0% | ||
| Q3 25 | 8.7% | 14.7% | ||
| Q2 25 | 2.7% | 13.5% | ||
| Q1 25 | 9.2% | 7.4% | ||
| Q4 24 | 7.9% | 10.9% | ||
| Q3 24 | 12.6% | 12.4% | ||
| Q2 24 | 3.2% | 7.1% | ||
| Q1 24 | 7.3% | 16.3% |
| Q4 25 | — | $0.15 | ||
| Q3 25 | — | $0.12 | ||
| Q2 25 | — | $0.10 | ||
| Q1 25 | — | $0.06 | ||
| Q4 24 | — | $0.08 | ||
| Q3 24 | — | $0.10 | ||
| Q2 24 | — | $0.05 | ||
| Q1 24 | — | $0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $121.0K | $63.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $176.9M | $106.6M |
| Total Assets | $217.2M | $118.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $121.0K | $63.6M | ||
| Q3 25 | $122.0K | $61.6M | ||
| Q2 25 | $56.5M | $65.6M | ||
| Q1 25 | $123.0K | $68.8M | ||
| Q4 24 | $121.0K | $70.0M | ||
| Q3 24 | $136.0K | $72.0M | ||
| Q2 24 | $56.5M | $74.4M | ||
| Q1 24 | $134.0K | $77.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $66.9K | — | ||
| Q1 24 | — | — |
| Q4 25 | $176.9M | $106.6M | ||
| Q3 25 | $174.9M | $105.8M | ||
| Q2 25 | $172.6M | $105.0M | ||
| Q1 25 | $171.9M | $107.2M | ||
| Q4 24 | $169.8M | $107.4M | ||
| Q3 24 | $168.7M | $110.3M | ||
| Q2 24 | $166.0M | $111.7M | ||
| Q1 24 | $165.8M | $112.9M |
| Q4 25 | $217.2M | $118.1M | ||
| Q3 25 | $218.4M | $116.4M | ||
| Q2 25 | $216.9M | $120.7M | ||
| Q1 25 | $214.9M | $122.1M | ||
| Q4 24 | $208.0M | $124.2M | ||
| Q3 24 | $212.3M | $125.1M | ||
| Q2 24 | $214.2M | $129.4M | ||
| Q1 24 | $209.6M | $132.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $171.0K | $5.1M |
| Free Cash FlowOCF − Capex | $-227.0K | $4.3M |
| FCF MarginFCF / Revenue | -0.9% | 24.6% |
| Capex IntensityCapex / Revenue | 1.6% | 4.8% |
| Cash ConversionOCF / Net Profit | 0.08× | 1.73× |
| TTM Free Cash FlowTrailing 4 quarters | $5.7M | $3.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $171.0K | $5.1M | ||
| Q3 25 | $1.7M | $-2.1M | ||
| Q2 25 | $4.2M | $1.6M | ||
| Q1 25 | $3.1M | $969.0K | ||
| Q4 24 | $2.2M | $2.7M | ||
| Q3 24 | $1.7M | $1.4M | ||
| Q2 24 | $4.6M | $-423.0K | ||
| Q1 24 | $2.8M | $5.3M |
| Q4 25 | $-227.0K | $4.3M | ||
| Q3 25 | $-177.0K | $-2.3M | ||
| Q2 25 | $3.6M | $1.1M | ||
| Q1 25 | $2.6M | $338.0K | ||
| Q4 24 | $1.5M | $2.7M | ||
| Q3 24 | $-148.0K | $1.3M | ||
| Q2 24 | $4.2M | $-435.0K | ||
| Q1 24 | $2.6M | $5.1M |
| Q4 25 | -0.9% | 24.6% | ||
| Q3 25 | -0.7% | -14.0% | ||
| Q2 25 | 13.1% | 7.2% | ||
| Q1 25 | 9.4% | 2.0% | ||
| Q4 24 | 6.0% | 18.6% | ||
| Q3 24 | -0.6% | 7.5% | ||
| Q2 24 | 16.1% | -3.1% | ||
| Q1 24 | 10.2% | 31.4% |
| Q4 25 | 1.6% | 4.8% | ||
| Q3 25 | 7.2% | 1.1% | ||
| Q2 25 | 2.4% | 3.1% | ||
| Q1 25 | 2.2% | 3.7% | ||
| Q4 24 | 3.0% | 0.4% | ||
| Q3 24 | 7.2% | 1.2% | ||
| Q2 24 | 1.6% | 0.1% | ||
| Q1 24 | 0.7% | 1.0% |
| Q4 25 | 0.08× | 1.73× | ||
| Q3 25 | 0.75× | -0.88× | ||
| Q2 25 | 5.79× | 0.76× | ||
| Q1 25 | 1.26× | 0.78× | ||
| Q4 24 | 1.14× | 1.73× | ||
| Q3 24 | 0.53× | 0.70× | ||
| Q2 24 | 5.54× | -0.43× | ||
| Q1 24 | 1.50× | 1.98× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FONR
| Managementof Diagnostic Imaging Centers | $23.2M | 91% |
| Manufacturingand Servicingof Medical Equipment | $2.4M | 9% |
PKE
| North America | $16.8M | 97% |
| Other | $546.0K | 3% |
